Levi M - Search Results

1

Humoral and cell-mediated immune responses in humans to the NSP4 enterotoxin of rotavirus.

Johansen K, Hinkula J, Espinoza F, Levi M, Zeng C, Rudén U, Vesikari T, Estes M, Svensson L. Johansen K, et al. Among authors: levi m. J Med Virol. 1999 Nov;59(3):369-77. J Med Virol. 1999. PMID: 10502271

2

Effects of adjuvants and multiple antigen peptides on humoral and cellular immune responses to gp160 of HIV-1.

Levi M, Rudén U, Birx D, Loomis L, Redfield R, Lövgren K, Akerblom L, Sandström E, Wahren B. Levi M, et al. J Acquir Immune Defic Syndr (1988). 1993 Aug;6(8):855-64. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8315572

3

Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.

Sandberg JK, Leandersson AC, Devito C, Kohleisen B, Erfle V, Achour A, Levi M, Schwartz S, Kärre K, Wahren B, Hinkula J. Sandberg JK, et al. Among authors: levi m. Virology. 2000 Jul 20;273(1):112-9. doi: 10.1006/viro.2000.0360. Virology. 2000. PMID: 10891413 Free article.

4

Induction of immune responses and break of tolerance by DNA against the HIV-1 coreceptor CCR5 but no protection from SIVsm challenge.

Zuber B, Hinkula J, Vödrös D, Lundholm P, Nilsson C, Mörner A, Levi M, Benthin R, Wahren B. Zuber B, et al. Among authors: levi m. Virology. 2000 Dec 20;278(2):400-11. doi: 10.1006/viro.2000.0633. Virology. 2000. PMID: 11118363 Free article.

5

Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies.

Levi M, Rudén U, Wahren B. Levi M, et al. Clin Diagn Lab Immunol. 1996 May;3(3):265-9. doi: 10.1128/cdli.3.3.265-269.1996. Clin Diagn Lab Immunol. 1996. PMID: 8705666 Free PMC article.

6

Immune responses to the HIV rev regulatory gene.

Wahren B, Brytting MM, Engström G, Hinkula J, Levi M, Ståhle EL, Ohlsson S, Rudén U, Schwartz S. Wahren B, et al. Among authors: levi m. Antibiot Chemother (1971). 1996;48:105-12. doi: 10.1159/000425164. Antibiot Chemother (1971). 1996. PMID: 8726512 No abstract available.

7

The use of peptides from glycoproteins G-2 and D-1 for detecting herpes simplex virus type 2 and type-common antibodies.

Levi M, Rudén U, Carlberg H, Wahren B. Levi M, et al. J Clin Virol. 1999 May;12(3):243-52. doi: 10.1016/s1386-6532(98)00065-1. J Clin Virol. 1999. PMID: 10382821

8

Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.

Jonsson MK, Levi M, Rudén U, Wahren B. Jonsson MK, et al. Among authors: levi m. Scand J Infect Dis. 2006;38(5):357-65. doi: 10.1080/00365540500488865. Scand J Infect Dis. 2006. PMID: 16709538

9

Mapping of B-cell epitopes in rabbits immunised with various gag antigens for the production of HIV-1 gag capture ELISA reagents.

Devito C, Levi M, Broliden K, Hinkula J. Devito C, et al. Among authors: levi m. J Immunol Methods. 2000 Apr 21;238(1-2):69-80. doi: 10.1016/s0022-1759(00)00141-1. J Immunol Methods. 2000. PMID: 10758237

10

Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.

Chin LT, Hinkula J, Levi M, Ohlin M, Wahren B, Borrebaeck CA. Chin LT, et al. Among authors: levi m. Immunology. 1994 Mar;81(3):428-34. Immunology. 1994. PMID: 7515847 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,853 results

Search Page

Filters